Literature DB >> 12000135

Cytokines and depression: an analogic approach.

M Corcos1, O Guilbaud, L Hjalmarsson, J Chambry, Ph Jeammet.   

Abstract

A growing body of evidence suggests that major depressive disorders may be accompanied by immune dysfunction and more particularly by an enhanced production of pro-inflammatory cytokines. The possible involvement of cytokines in depressive illness are based upon an analogic model. Pro-inflammatory cytokines are known to induce behavioral effects, and neuro-endocrine and immune activation similar to those observed in depression; these can be alleviated by antidepressant treatment. In this paper, we review research literature on the links between depressive illness and cytokine production and address further questions on this cytokine pathway. Further research is needed to see whether cytokines sustain specific depressive syndromes or whether cytokines induce depressive-like symptoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000135     DOI: 10.1016/s0753-3322(01)00156-1

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

Review 2.  Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.

Authors:  Glenda MacQueen; Pasqualina Santaguida; Homa Keshavarz; Natalia Jaworska; Mitchell Levine; Joseph Beyene; Parminder Raina
Journal:  Can J Psychiatry       Date:  2016-09-24       Impact factor: 4.356

3.  A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.

Authors:  J M Loftis; J M Wall; E Linardatos; S Benvenga; P Hauser
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

4.  The progesterone derivative dydrogesterone down-regulates neurokinin 1 receptor expression on lymphocytes, induces a Th2 skew and exerts hypoalgesic effects in mice.

Authors:  Arif Suphi Orsal; Sandra Blois; Dominika Labuz; Eva M J Peters; Martin Schaefer; Petra C Arck
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

Review 5.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

Review 7.  Interleukin 18 in the CNS.

Authors:  Silvia Alboni; Davide Cervia; Shuei Sugama; Bruno Conti
Journal:  J Neuroinflammation       Date:  2010-01-29       Impact factor: 8.322

8.  Diseases of poverty and lifestyle, well-being and human development.

Authors:  Ajai R Singh; Shakuntala A Singh
Journal:  Mens Sana Monogr       Date:  2008-01

9.  Involvement of Anti-Inflammatory and Stress Oxidative Markers in the Antidepressant-like Activity of Aloysia citriodora and Verbascoside on Mice with Bacterial Lipopolysaccharide- (LPS-) Induced Depression.

Authors:  Denise B Gomes; Patrícia Z Serpa; Daniela Miorando; Maria Eduarda D C Zanatta; Camila S Carteri; Lincon B Somensi; Larissa Venzon; Ana C Santos; Tauani C S França; Luísa M Silva; Walter A Roman Junior
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-22       Impact factor: 2.650

10.  Urinary interleukin-8 is a biomarker of stress in emergency physicians, especially with advancing age--the JOBSTRESS* randomized trial.

Authors:  Frédéric Dutheil; Marion Trousselard; Christophe Perrier; Gérard Lac; Alain Chamoux; Martine Duclos; Geraldine Naughton; George Mnatzaganian; Jeannot Schmidt
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.